The role of the CC chemokine, RANTES, in acute lung allograft rejection

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 461-472

  Belperio, John A ^b   Burdick, Marie D ^a   Keane, Michael P ^b   Xue, Ying Ying ^a   Lynch III, Joseph P ^b   Daugherty, Bruce L ^c   Kunkel, Steven L ^b   Strieter, Robert M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; GRAFT REJECTION; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034235699     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.461     Document Type: Article

References (59)

1. Trulock, E. P., T. M Egan, N. T. Kouchoukos, L. R. Kaiser, M. K. Pasque, N. Ettinger, J. D. Cooper, and W. U. L. T. Group. 1989. Single lung transplantation for severe chronic obstructive pulmonary disease. Chest 96:738.
2. Trulock, E. P. 1997. Lung transplantation. Am. J. Respir. Crit. Care Med. 155: 789.
3. Scott, J. P., T. W. Higenbottam, L. Sharples, C. A. Clelland, R. L. Smyth, S. Stewart, and J. Wallwork. 1991. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 51:813.
4. Reichenspurner, H., R. E. Girgis, R. C. Robbins, K. L. Yun, M. Nitschke, G. J. Berry, R. E. Morris, J. Theodore, and B. A Reitz. 1996. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann. Thorac. Surg. 62:1467.
5. Yousem, S. A., J. A. Dauber, R. Keenan, I. L. Paradis, A. Zeevi, and B. P. Griffith. 1991 Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 52:306.
6. Keller, C. A., P. T. Cagle, R. W. Brown, G. Noon, and A. E. Frost. 1995. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 107:973.
7. Taub, D. 1996. C-C chemokines: an overview. In Chemokines in Disease. A. Koch, and R. Strieter, eds. R. G. Landes, Co., Austin, p. 27.
8. + T cells in response to MIP-1α and MIP-1β. Science 260:355.
9. Rollins, B. J. 1997. Chemokines. Blood 90:909.
10. Strieter, R. M., and S. L. Kunkel. 1997. Chemokines and the lung. In Lung: Scientific Foundations, 2nd Ed. R. Crystal, J. West, E. Weibel, and P. Barnes, eds. Raven Press, New York, p. 155.
11. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25:64.
12. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669.
13. Power, C. A., A. Meyer, K. Nemeth, K. B. Bacon, A. J. Hoogewerf, A. E. Proudfoot, and T. N. Wells. 1995. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 270:19495.
14. Proudfoot, A. E., C. A. Power, A. Hoogewerf, M. O. Montjovent, F. Borlat, and T. N. Wells. 1995. Characterisation of the RANTES/MIP-1α receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands. FEBS Lett 376:19.
15. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
16. Samson, M., O. Labbe, C Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362.
17. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P. D. Ponath, and C R. Mackay. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178.
18. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, and O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272:15036.
19. Yamada, H., K. Hirai, M. Miyamasu, M. Iikura, Y. Misaki, S. Shoji, T. Takaishi, T. Kasahara, Y. Morita, and K. Ito. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231:365.
20. Hadida, F., V. Vieillard, B. Autran, I. Clark-Lewis, M. Baggiolini, and P. Debre. 1998. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J. Exp. Med. 188:609.
21. Prop, J., M. G. Ehrie, J. D. Crapo, P. Nieuwenhuis, and C. R. H. Wildevuur. 1984. Reimplantalion response in isografted rat lungs: analysis of causal factors. J. Thorac. Cardiovasc. Surg. 87:702.
22. Prop, J., P. Nieuwenhuis, and C. R. H. Wildevuur. 1985. Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes. Transplantation 40:25.
23. DeMeester, S. R., M. W. Rolfe, S. L. Kunkel, D. L. Swiderski, P. M. Lincoln, G. M. Deeb, and R. M. Strieter. 1993. The bimodal expression of tumor necrosis factor-α in association with rat lung reimplantation and allograft rejection. J. Immunol. 150:2494.
24. Rolfe, M. W., S. L. Kunkel, S. R. Demeester, D. L. Swiderski, P. M. Lincoln, G. M. Deeb, and R. M. Strieter. 1993. Expression of interleukin-6 in association with rat lung reimplantation and allograft rejection. Am. Rev. Respir. Dis. 147: 1010.
25. Rolfe, M. W., S. Kunkel, P. Lincoln, M. Deeb, F. Lupinetti, and R. Strieter. 1993. Lung allograft rejection: role of tumor necrosis factor-α and interleukin-6. Chest 103:133S.
26. Yousem, S. A., G. J. Berry, P. T. Cagle, D. Chamberlain, A. N. Husain, R. H. Hruban, A. Marchevsky, N. P. Ohori, J. Ritter, S. Stewart, et al. 1996. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J. Heart Lung Transplant. 15:1.
27. The BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 141:S188.
28. Marck, K. W., and C. R. Wildevuur. 1982. Lung transplantation in the rat: I. Technique and survival. Ann. Thorac. Surg. 34:74.
29. Barnes, D. A., J. Tse, M. Kaufhold, M. Owen, J. Hesselgesser, R. Strieter, R. Horuk, and H. D. Perez. 1998. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J. Clin. Invest. 101:2910.
30. Keane, M. P., J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg. R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Stricter. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleo-mycin-induced pulmonary fibrosis. J. Immunol. 162:5511.
31. Huffnagle, G. B., R. M. Stricter, L. K. McNeil, R. A. McDonald, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1997. Macrophage inflammatory protein-1α (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318.
32. Nadeau, K. C., H. Azuma, and N. L. Tilney. 1995. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc. Natl. Acad. Sci. USA 92:8729.
33. Sellner, L. N., R. J. Coelen, and J. S. Mackenzie. 1992. Reverse transcriptase inhibits Taq polymerase activity. Nucleic Acids Res. 20:1487.
34. Chumakov, K. M. 1994. Reverse transcriptase can inhibit PCR and stimulate primer-dimer formation. PCR Methods Appl. 4:62.
35. Chumakov, K. M., E. M. Dragunsky, L. P. Norwood, M. P. Douthitt, Y. Ran, R. E. Taffs, J. Ridge, and I. S. Levenbook. 1994. Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. J. Med. Virol. 42:79.
36. Lukacs, N. W., R. M. Strieter, H. I. Evanoff, M. D. Burdick, and S. L. Kunkel. 1994. VCAM-1 influences lymphocyte proliferation and cytokine production during mixed lymphocyte responses. Cell. Immunol. 154:88.
37. Eppinger, M. J., M. L. Jones, G. M. Deeb, S. F. Bolling, and P. A. Ward. 1995. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J. Surg. Res. 58:713.
38. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
39. Monti, G., A. Magnan, M. Fattal, B. Rain, M. Humbert, J. L. Mege, M. Noirclerc, P. Dartevelle, J. Cerrina, G. Simonneau, et al. 1996. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation 61:1757.
40. Broxmeyer, H. E., and C. H. Kim. 1999. Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp. Hematol. 27:1113.
41. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776.
42. Bonecchi, R., N. Polentarutti, W. Luini, A. Borsatti, S. Bernasconi, M. Locati, C. Power, A. Proudfoot, T. N. Wells, C. Mackay, et al. 1999. Up-regulation of CCRI and CCR3 and induction of chemotaxis to CC chemokines by IFN-γ in human neutrophils. J. Immunol. 162:474.
43. Ghorpade, A., M. Q. Xia, B. T. Hyman, Y. Persidsky, A. Nukuna, P. Bock, M. Che, J. Limoges, H. E. Gendelman, and C. R. Mackay. 1998. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72:3351.
44. Kondo, T., A. C. Novick, H. Toma, and R. L. Fairchild. 1996. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 61:1750.
45. Kondo, T., Y. Watarai, A. C. Novick, H. Toma, and R. L. Fairchild. 1997. T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts. Transplantation 63:732.
46. Nagano, H., K. C. Nadeau, M. Takada, M. Kusaka, and N. L. Tilney. 1997. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 63:1101.
47. Pattison, J., P. J. Nelson, P. Huie, I. von Leuttichau, G. Farshid, R. K. Sibley, and A. M. Krensky. 1994. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 343:209.
48. Otulana, B. A., T. Higenbottam, L. Ferrari, J. Scott, G. Igboaka, and J. Wallwork. 1990. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest 97:353.
49. VanOtteren, G. M., R. M. Stricter, S. L. Kunkel, R. Paine III, M. J. Greenberger, J. M. Danforth, M. D. Burdick, and T. J. Standiford. 1995. Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154: 1900.
50. Grone, H. J., C. Weber, K. S. Weber, E. F. Grone, T. Rabelink, C. M. Klier, T. N. Wells, A. E. Proudfoot, D. Schlondorff, and P. J. Nelson. 1999. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 13:1371.
51. Stellato, C., L. A Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and R. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J. Immunol. 155:410.
52. Rathanaswami, P., M. Hachicha, M. Sadick, T. J. Schall, and S. R. McColl. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 268:5834.
53. Marfaing-Koka, A., O. Devergne, G. Gorgone, A. Portier, T. J. Schall, P. Galanaud, and D. Emilie. 1995. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1870.
54. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727.
55. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulaled by tumor necrosis factor α. J. Exp. Med. 179:1109.
56. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480.
57. Sallusto, F., and A. Lanzavecchia. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611.
58. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J Immunol. 28:2760.
59. + T cells. J. Exp. Med. 186:239.